![Jeffrey James Roix](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey James Roix
Directeur Général chez
Stingray Bio Ltd.
Profil
Jeffrey James Roix currently works at Stingray Bio Ltd., as Chief Executive Officer, Opal Therapeutics Ltd., as Director from 2021, and o2h Ltd, as Venture Partner from 2020.
Mr. Roix also formerly worked at NeoPhore Ltd., as Chief Executive Officer & Director and PhoreMost Ltd., as Chief Operating Officer from 2015 to 2018.
Mr. Roix received his undergraduate degree from Harvard Extension School.
Postes actifs de Jeffrey James Roix
| Sociétés | Poste | Début |
|---|---|---|
Stingray Bio Ltd.
 Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Directeur Général | - |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01/07/2020 |
Opal Therapeutics Ltd.
 Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Directeur/Membre du Conseil | 01/03/2021 |
Anciens postes connus de Jeffrey James Roix
| Sociétés | Poste | Fin |
|---|---|---|
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Directeur des opérations | 01/04/2018 |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Directeur Général | - |
Formation de Jeffrey James Roix
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Harvard Extension School
 Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
Stingray Bio Ltd.
Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Commercial Services |
